HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshiko Iwamoto Selected Research

Demyelinating Diseases (Demyelinating Disease)

10/2019Myeloperoxidase Molecular MRI Reveals Synergistic Combination Therapy in Murine Experimental Autoimmune Neuroinflammation.
5/2012Demyelinating diseases: myeloperoxidase as an imaging biomarker and therapeutic target.
1/2012Ligation of the jugular veins does not result in brain inflammation or demyelination in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshiko Iwamoto Research Topics

Disease

24Inflammation (Inflammations)
10/2022 - 11/2010
17Neoplasms (Cancer)
06/2022 - 02/2004
12Atherosclerosis
01/2022 - 01/2012
12Myocardial Infarction
12/2017 - 07/2009
9Infarction (Infarctions)
12/2016 - 11/2010
6Atherosclerotic Plaque (Atheroma)
10/2020 - 05/2011
5Heart Failure
04/2024 - 04/2014
5Multiple Sclerosis
11/2023 - 05/2012
5Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
10/2019 - 01/2012
4Atrial Fibrillation
01/2023 - 04/2012
4Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 12/2016
4Hypertension (High Blood Pressure)
01/2019 - 01/2014
3Infections
01/2022 - 06/2014
3Neuroinflammatory Diseases
10/2019 - 01/2012
3Demyelinating Diseases (Demyelinating Disease)
10/2019 - 01/2012
3Ischemia
11/2017 - 11/2010
3Rupture
11/2017 - 07/2012
2Obesity
10/2022 - 01/2019
2Fibrosis (Cirrhosis)
12/2020 - 12/2015
2Endocarditis
11/2020 - 08/2011
2Myocarditis (Carditis)
01/2019 - 06/2015
2Non-alcoholic Fatty Liver Disease
01/2017 - 12/2015
2Chronic Disease (Chronic Diseases)
01/2016 - 05/2015
2Stroke (Strokes)
07/2014 - 07/2012
2Wounds and Injuries (Trauma)
04/2014 - 11/2010
2Disease Progression
03/2013 - 04/2009
1Pre-Eclampsia (Preeclampsia)
04/2024
1COVID-19
03/2024
1Cardiac Arrhythmias (Arrythmia)
07/2022
1Ventricular Tachycardia
07/2022
1Human Influenza (Influenza)
01/2022
1Squamous Cell Carcinoma of Head and Neck
01/2022
1Anaplastic Thyroid Carcinoma
01/2021
1Alzheimer Disease (Alzheimer's Disease)
01/2021
1Communicable Diseases (Infectious Diseases)
11/2020
1Diabetes Mellitus
01/2020
1Lung Injury
11/2019

Drug/Important Bio-Agent (IBA)

13Peroxidase (Myeloperoxidase)IBA
01/2022 - 07/2011
9Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2010
7EnzymesIBA
01/2022 - 02/2004
6Apolipoproteins E (ApoE)IBA
11/2015 - 11/2010
5Interleukin-3 (Interleukin 3)IBA
11/2023 - 01/2012
5CytokinesIBA
03/2015 - 12/2012
4Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
11/2017 - 01/2012
3Matrix Metalloproteinases (MMPs)IBA
02/2019 - 01/2012
3ChemokinesIBA
01/2019 - 01/2012
3LipidsIBA
01/2016 - 05/2011
3CollagenIBA
09/2015 - 06/2013
3Chemokine ReceptorsIBA
06/2015 - 02/2012
3Messenger RNA (mRNA)IBA
06/2015 - 10/2011
3Small Interfering RNA (siRNA)IBA
06/2015 - 05/2013
2Contrast MediaIBA
01/2022 - 01/2012
2Pentetic Acid (DTPA)FDA LinkGeneric
01/2022 - 05/2015
2Leptin ReceptorsIBA
01/2020 - 11/2019
24-aminobenzhydrazideIBA
10/2019 - 02/2019
2Losartan (Cozaar)FDA LinkGeneric
01/2018 - 01/2015
2Angiotensin Receptor AntagonistsIBA
01/2018 - 01/2015
2Hydrochlorothiazide (Esidrix)FDA LinkGeneric
01/2018 - 01/2015
2Therapeutic UsesIBA
12/2016 - 06/2015
2GadoliniumIBA
05/2015 - 07/2011
2Peptide Hydrolases (Proteases)FDA Link
04/2014 - 01/2012
2ApolipoproteinsIBA
05/2013 - 11/2010
2Factor XIII (Coagulation Factor XIII)IBA
05/2013 - 11/2012
2Gadolinium DTPA (Magnevist)FDA Link
01/2012 - 01/2012
2salicylhydroxamic acid (SHAM)IBA
01/2012 - 01/2012
1Proteins (Proteins, Gene)FDA Link
04/2024
1activin AIBA
04/2024
1Angiotensin-Converting Enzyme 2IBA
03/2024
1Toll-Like Receptors (Toll-Like Receptor)IBA
03/2024
1LigandsIBA
03/2024
1Phosphotransferases (Kinase)IBA
10/2022
1SodiumIBA
10/2022
1GlucocorticoidsIBA
10/2022
1c-Mer Tyrosine KinaseIBA
07/2022
1Lipocalin-2IBA
07/2022
1HydrogelsIBA
06/2022
1Acetylcholine (Acetylcholine Chloride)FDA Link
01/2022
1Interleukin-6 (Interleukin 6)IBA
01/2022
1Corticotropin-Releasing HormoneIBA
01/2022
1CarcinogensIBA
01/2022
1Versicans (Versican)IBA
01/2022
12- (1,1- dicyanopropenyl- 2- )- 6- dimethylaminonaphthaleneyIBA
01/2021
1Ferrosoferric Oxide (Magnetite)FDA Link
01/2021
1B7-H1 AntigenIBA
01/2021
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2021
1Amyloid (Amyloid Fibrils)IBA
01/2021
1CSK Tyrosine-Protein KinaseIBA
12/2020
1ibrutinibIBA
12/2020
1Agammaglobulinaemia Tyrosine KinaseIBA
12/2020
1Virulence Factors (Pathogenicity Factors)IBA
11/2020
1Streptozocin (Streptozotocin)FDA Link
01/2020
1Growth Factor ReceptorsIBA
01/2020
1ErbB Receptors (EGF Receptor)IBA
11/2019
1LeptinIBA
11/2019
1Glatiramer Acetate (Copaxone)FDA Link
10/2019
1Immunomodulating AgentsIBA
10/2019

Therapy/Procedure

14Therapeutics
01/2021 - 04/2009
6Ligation
09/2016 - 11/2010
4Immunotherapy
01/2023 - 02/2016
1Intravenous Administration
10/2020